| 2020 | AKERS BIOSCIENCES INVESTOR ALERT BY : Kahn Swick & Foti, LLC Investigates Merge.. | BU |
| 2020 | AKERS BIOSCIENCES : ' Proposed Merger Partner MyMD Pharmaceuticals Announces Iss.. | BU |
| 2020 | AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | REMINDER : Akers Biosciences Schedules Conference Call to Discuss Merger with My.. | BU |
| 2020 | AKERS BIOSCIENCES INVESTOR ALERT BY : Kahn Swick & Foti, LLC Investigates Merge.. | BU |
| 2020 | AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events (form 8-K) | AQ |
| 2020 | AKERS BIOSCIENCES : Entry into a Material Definitive Agreement, Unregistered Sal.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister.. | AQ |
| 2020 | AKERS MERGER INVESTIGATION : Halper Sadeh LLP Announces Investigation Into Wheth.. | BU |
| 2020 | Akers Biosciences, MyMD Pharmaceuticals Ink Merger Agreement | MT |
| 2020 | AKERS BIOSCIENCES : and MyMD Pharmaceuticals Sign Definitive Merger Agreement | BU |
| 2020 | AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Material M.. | AQ |
| 2020 | AKERS BIOSCIENCES : Change in Directors or Principal Officers, Submission of Mat.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Submission .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exh.. | AQ |
| 2020 | AKERS BIOSCIENCES : Quarterly report | PU |
| 2020 | AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Amendments .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Financial S.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Shareholder Director Nominations (form 8-K) | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Other Even.. | AQ |
| 2020 | AKERS BIOSCIENCES : and Premas Biotech Announce Successful Completion of Vaccine.. | AQ |
| 2020 | Here's How Akers Biosciences and Premas Biotech Plan To Knock Out COVID-19 Vi.. | NE |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events (form 8-K) | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Other Events, Financial Statements and Exhibits (form .. | AQ |
| 2020 | AKERS BIOSCIENCES : Management's Discussion and Analysis of Financial Condition .. | AQ |
| 2020 | AKERS BIOSCIENCES : Schedules Conference Call to Discuss Licensing Announcement .. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Entry into a Material Definitive Agreement, Unregister.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers (form 8-K) | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Regulation FD Disclosure, Financial Statements and Exh.. | AQ |
| 2020 | AKERS BIOSCIENCES, INC. : Change in Directors or Principal Officers, Amendments .. | AQ |
| 2019 | AKERS BIOSCIENCES : Announces Closing of Approximately $8 Million Public Offerin.. | AQ |
| 2019 | AKERS BIOSCIENCES, INC. : Other Events (form 8-K) | AQ |
| 2019 | AKERS BIOSCIENCES, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fi.. | AQ |
| 2019 | Akers Biosciences Reports Fiscal Year 2018 Earnings | GL |
| 2019 | AKERS BIOSCIENCES : Cancellation - Akers Biosciences, Inc. | PU |
| 2019 | AKERS BIOSCIENCES : Result of Special Meeting of Shareholders | PU |
| 2019 | AKERS BIOSCIENCES : Holding in Company | PU |
| 2019 | AKERS BIOSCIENCES : Form DEFA14A Filing - Additional Proxy Materials | PU |
| 2019 | AKERS BIOSCIENCES : Notice of Special Meeting of Shareholders | PU |
| 2019 | AKERS BIOSCIENCES : Further Re. Directorate Change | PU |
| 2018 | AKERS BIOSCIENCES : Intention to Delist from AIM | PU |
| 2018 | AKERS BIOSCIENCES : Result of AGM & Form 8-K Filing | PU |
| 2018 | AKERS BIOSCIENCES : Further Re. Notice of AGM | PU |
| 2018 | AKERS BIOSCIENCES : Further Re. Strategic Update | PU |
| 2018 | AKERS BIOSCIENCES : Reverse Stock Split Update | PU |
| 2018 | Akers Biosciences Announces Q3 2018 Earnings | GL |
| 2018 | AKERS BIOSCIENCES : 3rd Quarter 2018 Results | PU |
| 2018 | AKERS BIOSCIENCES : Notice of AGM | PU |
| 2018 | AKERS BIOSCIENCES : Form 8-K Filing | PU |
| 2018 | AKERS BIOSCIENCES INC : REVERSE SPLIT: 1 of 8 | FA |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
